ETC
KRYS icon

Exchange Traded Concepts’s Krystal Biotech KRYS Stock Holding History

Exchange Traded Concepts’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$265K Buy
714
+26
+4% +$7.77K ﹤0.01% 1291
2026
Q1 		$178K Sell
688
-238
-26% -$63.3K ﹤0.01% 1261
2025
Q4 		$228K Buy
926
+430
+87% +$90.5K ﹤0.01% 1217
2025
Q3 		$87.6K Buy
+496
New +$74.2K ﹤0.01% 1263

Other funds holding KRYS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Exchange Traded Concepts's KRYS Position: Q2 2026 in Review

Exchange Traded Concepts increased its Krystal Biotech (KRYS) stake by 3.8% in Q2 2026, buying an estimated $7.77K and bringing the position to 714 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1291.

Exchange Traded Concepts first reported a position in KRYS in Q3 2025 and has held it in 4 quarters since. 74 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Exchange Traded Concepts held 714 shares of Krystal Biotech worth $265K as of Q2 2026.
  • Exchange Traded Concepts bought 26 Krystal Biotech shares in Q2 2026, an estimated $7.77K.
  • Krystal Biotech made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #1291 holding.
  • Exchange Traded Concepts first reported a position in Krystal Biotech in Q3 2025 and has held it in 4 quarters since.
  • 74 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.